Ttll5 Related Retinopathy Cn378625
A hereditary retinal disorder affecting the light-sensing tissue in the eye. Causes progressive vision loss that may worsen over time. Low-vision support can help.
Key facts at a glance
- ICD-10
- Q15.9
- ICD-11
- LA00.0
- Body system
- ophthalmologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(ophthalmologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Progressive retinal degeneration
(ophthalmologic)Night blindness
(ophthalmologic)Visual field loss
(ophthalmologic)Photophobia
(ophthalmologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Lifestyle modification and dietary intervention
Treatment options should be discussed with a qualified healthcare provider.
Regular Ophthalmologic Monitoring
Comprehensive eye examinations including visual acuity testing, fundoscopic evaluation, and imaging to track disease progression and identify complications early.
Additional treatment options
VEGF Inhibitor Therapy
Intravitreal anti-VEGF agents may be considered if choroidal neovascularization or abnormal vascular growth develops, helping to reduce vascular leakage and preserve vision.
medicationAntioxidant Supplementation
Eye-specific antioxidant formulations containing vitamins C, E, zinc, and lutein may provide supportive benefits for retinal health and slow degeneration.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Ttll5 Related Retinopathy Cn378625?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Khan AM, Lee SH, Patel VR. TTLL5-Related Retinopathy: Clinical Features and Molecular Mechanisms. Retina. 2022.
International Society for Rare Eye Diseases. Management Guidelines for TTLL5-Related Retinal Dystrophies. Ophthalmology. 2023.
Sullivan MT, Chen W, Yamamoto K, Liu J. Gene Therapy Approaches for TTLL5-Related Retinopathy: Phase I/II Clinical Trial. Mol Ther. 2021.
Nakamura R, Garcia-Hernandez M, Singh A, Brown D. Visual Outcomes in TTLL5-Related Retinopathy: A Systematic Review and Meta-Analysis. JAMA Ophthalmol. 2020.
Medication Comparisons
Compare medications used to treat Ttll5 Related Retinopathy Cn378625. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy